PM360 July 13, 2023 Read the full article>> Reasons for Discontinuation (RfD) Analytics Report An estimated 50% of patients with a prescription for a chronic condition stop taking it within the first year, leading to worse outcomes and nearly $250 billion lost revenue annually for the pharmaceutical industry. To combat this, OM1 launched its Reasons for Discontinuation[…]
View our poster on A Cross-Sectional Study of Rheumatoid Arthritis (RA) Diagnoses in Patients with Systemic Lupus Erythematosus (SLE). Click to view more!
Inside Precision Medicine Published Online: August 18, 2022 Read the Full Article >> Artificial intelligence (AI) has promised major breakthroughs in clinical development success. While the hype has sometimes seemed overblown, AI is starting to deliver on those promises through real-world impact. AI is not a silver bullet for all challenges, but in specific applications,[…]
BioPharma Dive Published Online: July 18, 2022 Read the Full Article>> Identifying patients ‘outside the clinic’ can provide significant benefits for researchers and population health managers. Better understanding of patient cohorts can shed light on patient journeys, help optimize decisions around treatment choice and timing and inform the development of new therapies and intervention programs.[…]
Sage Journals Published June 22, 2022 Read the Full Manuscript>> Abstract Background Disability assessment using the Expanded Disability Status Scale (EDSS) is important to inform treatment decisions and monitor the progression of multiple sclerosis. Yet, EDSS scores are documented infrequently in electronic medical records. Objective To validate a machine learning model to estimate EDSS scores[…]
